Idiopathic ventricular arrhythmias (VAs) are comprised of ventricular premature depolarisations, non-sustained ventricular tachycardia (VT) and rarely sustained VT, and these typically occur in the absence of structural heart disease. In general, idiopathic VAs tend to have a benign prognosis, although a high burden of VAs can result in left ventricular (LV) systolic dysfunction and cardiomyopathy and, rarely, outflow tract (OT) VAs can serve as a trigger for idiopathic VF. The mechanism of these arrhythmias tends to be triggered activity or abnormal automaticity and this usually manifests as a focal source.
anterior fascicular block, as these patients were excluded or not well represented in the original study cohort. 2 Another relatively simpler method to differentiate RVOT from LVOT SOO of VAs manifesting LBBB morphology and inferior axis is to calculate the V2S/V3R ratio during OT VA. Yoshida et al. showed that a V2S/V3R cutoff value of ≤1.5 predicted LVOT origin with 89% sensitivity and 94% specificity. 3 Furthermore, for PVCs with LBBB and rightward inferior axis (with R<S in leads I and V1), measuring the R wave amplitude in lead I can differentiate RVOT from LVOT SOO. For these patients, Xie et al. showed that the presence of R wave amplitude ≥0.1 mV in lead I predicted site of successful ablation from the aortic sinuses of Valsalva or LV endocardium with 75% sensitivity and 98.2% specificity. 4 
Right Ventricular Outflow Tract
OT VAs can originate from the septal or free wall aspect of the RVOT beneath the pulmonic valve, or from above the pulmonic valve.
Our group has previously reported typical ECG findings of OT VAs from different locations within the RVOT based on pace mapping in structurally normal hearts. [5] [6] [7] Septal versus free wall RVOT site of origin can be distinguished based on QRS morphology. Leads II, III and aVF tend to be taller and narrower for septal compared versus free wall sites within the RVOT. Meanwhile, VAs originating from the free wall of the RVOT tend to manifest later precordial transition (≥V4) and more frequently exhibit notching of the QRS in the inferior leads. 5 The septal and free wall aspects of the subpulmonic RVOT can be further segmented into nine different anatomic sites ( Figure 1 ). 7 Sites 1-3 represent the most superior sites just beneath the pulmonic valve, with site 1 being most posterior and site 3 being most anterior. Sites [4] [5] [6] are just inferior to sites 1-3, while sites 7-9 are the most inferior sites and within close proximity to the bundle of His region (RV inflow tract). Lead I can be helpful in differentiating between the posterior (more rightward, positive QRS morphology in lead I) and anterior (more leftward, negative QRS morphology in lead I) sites in the superior RVOT (sites 1,2 and 3 in Figure 1 ).
RVOT VAs are increasingly being recognised to originate from supravalvular myocardial extensions above the pulmonic valve. [8] [9] [10] [11] [12] These VAs manifest similar ECG features as those arising from the • LV endocardium beneath the aortic valve;
• aortic sinus of Valsalva;
• septal RVOT;
• coronary venous system (great cardiac vein and/or anterior interventricular vein); and
• direct epicardial approach.
The latter can be performed in the EP laboratory (using the Sosa technique for epicardial access) or surgically. In rare instances, ablation of LV summit VAs has also been accomplished from the left atrial appendage. 19 within close proximity to the left anterior descending coronary artery. 20 Lin et al. proposed using the aVL/aVR Q wave ratio for predicting the successful ablation site for LV summit VAs. 21 In their study, an aVL/aVR ratio ≤1.415 was associated with successful ablation from the aortic sinuses of Valsalva, a ratio of 1.416-1.535 for successful ablation from the subvalvular LV, a ratio of 1.536-1.740 for successful ablation from the great cardiac vein/anterior inter-ventricular vein, while a ratio of >1.74 required direct epicardial ablation approach. In our experience, ECG predictors of successful ablation of LV summit VAs via a direct epicardial approach include aVL/aVR Q wave ratio >1.85, a V1 R/S ratio >2, and absence of Q waves in V1.
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Pearls and Pitfalls for Mapping and Ablation
Since the underlying mechanism of idiopathic OT VAs is most frequently triggered activity and the source is focal, activation mapping antiarrhythmic medications should be withdrawn, ideally for at least five half-lives prior to the procedure date. If amiodarone is being used to achieve arrhythmia control, then our practice is to hold this drug for at least 2 weeks in advance. Ablation should be performed with minimal anaesthesia if possible, as sedation frequently can suppress these VAs. We usually avoid using propofol and benzodiazepines for sedation during these procedure and instead use remifentanyl due to its ultra-short half-life. 23 Frequently, with administration of even minimal sedation at the beginning of the case (i.e. for urinary catheter insertion or venous/arterial access), VAs may disappear completely.
It is therefore vital that at least some examples of the clinical VA are captured on the recording system at the beginning of the case. Having this allows for pace mapping, which can be helpful to identify the SOO.
We have found that automatic pace mapping algorithms, such as PASO (CARTO, Biosense Webster) and AutoMap Score Threshold (EnSite Precision™) can be helpful to facilitate pace mapping. However, in our experience, the pace mapping algorithms utilised by different electroanatomic mapping platforms are not completely reliable because they can show a high level of similarity (>90%) between the pace maps and the VA over a large area (5-10 mm). It is important that ablation guided by a pace mapping approach should be delivered to the site(s) that are perfect matches. 26 Recent advances in electroanatomic mapping systems, including the PASO and Score 
The left ventricular summit (LVS) is a triangular region of the epicardial left ventricle. The apex of the triangle is formed by the bifurcation of the left anterior descending and left circumflex (LCx) arteries, while the base is formed by an arc connecting the first septal perforator branch with the LCx (white dotted line). The great cardiac vein bisects the LVS, separating it into two regions (blue and yellow dotted lines
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Challenging Situations
QRS Morphology Shift During Ablation
The myocardial network in the OT region is extremely complex, and the wavefront from the VA origin site can spread based on myofibre orientation, resulting in variable exit sites. 26 As such, on some occasions, ablation at the site of earliest activation may result in change in QRS morphology and intracardiac activation pattern (often with initial transient suppression but late recurrence with different QRS morphology during the waiting period). In our experience, this phenomenon occurs in 4% of cases. 32 In the majority (65%) of these cases, repeat mapping identified a new earliest site in the adjacent chamber within close proximity to the initial ablation site, while 35% of patients had the altered recurrent VA originating from the same chamber where the original VA was targeted. Regardless of the origin of the altered VA, repeat ablation of the new site was highly effective in achieving durable VA elimination. 32 
Ablation of Outflow Tract Ventricular Arrhythmias with Earliest Activation from the Coronary Venous System
When the earliest activation site of OT VA is recorded within the coronary venous system, ablation can be challenging and different ablation strategies should be considered. We have previously reported outcomes of ablation of VAs from the coronary venous system demonstrating that ablation delivery at the earliest activation site, although effective, is precluded in the majority (62%) of cases due to anatomic constraints (inability to advance ablation catheter and proximity to coronary arteries). 33 In these scenarios we have successfully utilised the strategy of getting as close as possible to the SOO from adjacent locations such as the basal LV endocardium, cusp region and/or the septal RVOT. We recently reported the outcome of this strategy in 53 consecutive patients where the earliest activation site was localised to the coronary venous system. 34 We were able to successfully target the clinical VA from adjacent locations in nearly half of these cases. We found that the anatomical distance between the coronary venous system site and the adjacent ablation site to be the only factor in predicting success. A cut-off distance >12.8 mm between the SOO and the ablation site strongly predicted failure. In those cases alternative ablation strategy such as simultaneous unipolar or bipolar ablation from two anatomically adjacent sites, half-normal saline use or retrograde coronary venous ethanol infusion may be considered.
Conclusion
Catheter ablation is a safe and effective treatment option for patients with OT VAs. The 12-lead ECG of the clinical VA is the most important piece of information for procedural preparation. Ablation success rates are highest when VA is spontaneous or inducible at the time of procedure, which allows for detailed activation mapping. While OT VAs with SOO that are intramural or adjacent to coronary arteries can be challenging to treat, different strategies can be attempted to overcome these difficulties. Use of intracardiac echocardiography has enhanced our ability to map and successfully target the vast majority of OT VAs.
Clinical Perspective
• Catheter ablation is a safe and effective treatment option for outflow tract (OT) ventricular arrhythmias (VAs).
• The 12-lead ECG is critical in accurately predicting the site of origin of OT VAs.
• Ablation success rates are highest when VA is spontaneously seen or reproducibly induced at the time of procedure, which allows for both activation and pace mapping.
• Ablation of OT VAs can be sometimes challenging due to anatomic constraints. Different strategies can be utilised to overcome these difficulties.
